What is DaShenLin Pharmaceutical Group Co OCF Yield %?
DaShenLin Pharmaceutical Group CoSHSE:603233 94 OCF Yield % is 22.64 as of Jul. 10, 2026, which is 266% above its 10-year median of 6.18. GuruFocus rates SHSE:603233 with a GF Score™ of 94/100 and a GF Value™ of ¥18.77 (Fairly Valued). The stock has 4 warning signs investors should review. Among 683 Healthcare Providers & Services companies, DaShenLin Pharmaceutical Group Co ranks better than 88.58% on this metric.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
SHSE:603233'
s OCF Yield % Range Over the Past 10 Years
Min: 1.75 Med: 6.18 Max: 27.07
Current: 22.64
During the past 13 years, the highest OCF Yield % of DaShenLin Pharmaceutical Group Co was 27.07%. The lowest was 1.75%. And the median was 6.18%.
SHSE:603233's OCF Yield % is ranked better than 88.58% of 683
companies
in the Healthcare Providers & Services industry
Industry Median: 5.49
vs SHSE:603233: 22.64
DaShenLin Pharmaceutical Group Co OCF Yield % Explanation
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
DaShenLin Pharmaceutical Group Co OCF Yield % Related Terms
DaShenLin Pharmaceutical Group Co OCF Yield % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DaShenLin Pharmaceutical Group Co OCF Yield % Chart
DaShenLin Pharmaceutical Group Co OCF Yield % Competitor Comparison
For the Pharmaceutical Retailers subindustry, DaShenLin Pharmaceutical Group Co's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
DaShenLin Pharmaceutical Group Co OCF Yield % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, DaShenLin Pharmaceutical Group Co's OCF Yield % distribution charts can be found below:
* The bar in red indicates where DaShenLin Pharmaceutical Group Co's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DaShenLin Pharmaceutical Group Co (SHSE:603233) has a OCF Yield % of 22.64 as of Jul. 10, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on DaShenLin Pharmaceutical Group Co and its competitors. This is 266% above median its historical median of 6.18. Over the past decade, DaShenLin Pharmaceutical Group Co's OCF Yield % has ranged from 1.75 to 27.07. According to the industry distribution chart, DaShenLin Pharmaceutical Group Co ranks #78 out of 683 companies in the Healthcare Providers & Services industry, placing it in the top 11.4%.
Is DaShenLin Pharmaceutical Group Co's OCF Yield % too high?
DaShenLin Pharmaceutical Group Co's current OCF Yield % of 22.64 is 266% above median its 10-year median of 6.18. Over the past 10 years, this metric has ranged from a low of 1.75 to a high of 27.07. The Healthcare Providers & Services industry median OCF Yield % is 5.49. DaShenLin Pharmaceutical Group Co's value of 22.64 is 312.4% above this industry median. Based on the distribution chart, DaShenLin Pharmaceutical Group Co ranks #78 out of 683 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, DaShenLin Pharmaceutical Group Co has a GF Score™ of 94/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does DaShenLin Pharmaceutical Group Co's OCF Yield % compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, DaShenLin Pharmaceutical Group Co ranks #78 out of 683 companies for OCF Yield %. This places DaShenLin Pharmaceutical Group Co in the top 11% of its industry — outperforming the majority of peers. The industry median OCF Yield % is 5.49. DaShenLin Pharmaceutical Group Co's value of 22.64 is 312.4% above this benchmark. Historically, DaShenLin Pharmaceutical Group Co's own OCF Yield % has ranged from 1.75 to 27.07 over the past decade. While the company's 10-year median is 6.18 vs. the industry median of 5.49, DaShenLin Pharmaceutical Group Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Healthcare Providers & Services company?
The median OCF Yield % among Healthcare Providers & Services companies is 5.49, based on 683 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. DaShenLin Pharmaceutical Group Co's current OCF Yield % of 22.64 is 312.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on DaShenLin Pharmaceutical Group Co and its competitors. For the Healthcare Providers & Services industry, the median OCF Yield % is 5.49 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. DaShenLin Pharmaceutical Group Co's current OCF Yield % is 22.64, which is 266% above median its own 10-year median of 6.18. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DaShenLin Pharmaceutical Group Co stock overvalued right now?
Based on GuruFocus' analysis, DaShenLin Pharmaceutical Group Co (SHSE:603233) is currently considered Fairly Valued. The stock's GF Value™ is ¥18.77, compared to a current price of ¥17.65 — trading 6% below its estimated fair value. The current OCF Yield % is 22.64, which is 266% above median its 10-year median of 6.18 and 312.4% above the Healthcare Providers & Services industry median of 5.49. DaShenLin Pharmaceutical Group Co's overall GF Score™ is 94/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For DaShenLin Pharmaceutical Group Co (SHSE:603233), the current OCF Yield % is 22.64 as of Jul. 10, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is DaShenLin Pharmaceutical Group Co (SHSE:603233) Overvalued in 2026?
Based on GuruFocus' analysis, DaShenLin Pharmaceutical Group Co stock appears to be undervalued.
The current stock price of ¥17.65 is trading 6% below its estimated GF Value™ of ¥18.77.
GuruFocus considers DaShenLin Pharmaceutical Group Co to be Fairly Valued.
Key valuation signals for SHSE:603233:
OCF Yield %: 22.64 (266% above median its 10-year median of 6.18)
GF Value™: ¥18.77 vs. price of ¥17.65 (6% below fair value)
Industry Position: 312.4% above the Healthcare Providers & Services median (#78 of 683)
No single metric tells the full story. See the SHSE:603233 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
DaShenLin Pharmaceutical Group Co Business Description
DaShenLin Pharmaceutical Group Co Ltd is engaged in the pharmaceutical manufacturing, retail, and wholesale business. The company is based on the development of the pharmacy chain. It primarily offers Chinese herbal medicine such as antibiotics and biochemical drugs. The business activities are geographically carried out through China.
94GF Score
Get the complete analysis for SHSE:603233
OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:603233 has been successfully added to your 
